There have been few thorough investigations on the effect of adrenaline on the systemic absorption of bupivacaine from the extradural space in pregnant women, and controversy remains. Reynolds and Taylor [1] reported that extradural adrenaline slightly decreased the plasma concentrations of bupivacaine during labour with no prolongation of analgesia. Reynolds, Hargrove and Wyman [2] demonstrated a significant decrease in plasma concentrations at delivery after 0.5 % bupivacaine with adrenaline for extradural analgesia during labour. Abboud and colleagues [3] reported prolongation of analgesia, but no significant effect on plasma bupivacaine concentrations following extradural adrenaline. Symptoms of bupivacaine toxicity are observed rarely during labour, but the large doses used for Caesarean section may result in plasma concentrations which approach or exceed the threshold for systemic toxicity [4, 5] . In emergency Caesarean section, moreover, a large dose of bupivacaine after prolonged administration during labour may result in systemic toxicity [6] .
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If the systemic absorption of bupivacaine is significantly decreased by adrenaline, women receiving a large dose of bupivacaine for Caesarean section may benefit most from this effect. We have investigated the effect of adrenaline 1 in 
SUMMARY

Extradural technique
For elective Caesarean section, the mid-lumbar extradural space was located with a 16-gauge Tuohy needle. The local anaesthetic was injected through the needle and the extradural catheter inserted subsequently. This method is reported in detail elsewhere [7] . For emergency Caesarean section, all mothers had already received plain bupivacaine via an extradural catheter during labour, and the dose for Caesarean section was injected through the catheter. In all cases a 2-ml test dose was followed after 5 min by the remaining 18 ml of local anaesthetic injected over 5 min. All patients were in the left lateral position during the injection and then turned to the other side for a further 5 min. After this, they were placed supine with a wedge under the right buttock.
The onset and progress of the extradural block was assessed over 30 min at 5-min intervals as described in detail elsewhere [7] . If the height of the block was below T6 at 20 min, a supplementary dose (up to 10 ml) of 0.5 % plain bupivacaine was administered. Nitrous oxide, i.v. opioids or supplementary 0.5 % plain bupivacaine were administered if pain or discomfort occurred during surgery.
All patients were observed closely for the development of hypotension (systolic arterial pressure < 100 mm Hg), nausea and symptoms of bupivacaine toxicity (drowsiness, circumoral paraesthesia, hearing changes). Hypotension was treated by increasing the rate of the infusion of Hartmann's solution, and by the administration of ephedrine 15 mg i.m. and 15 mg i.v. Nausea was treated by correction of any associated hypotension and i.v. metoclopramide. All women received oxygen via MC mask until delivery, when Syntocinon 10 units i.v. was administered slowly.
Bupivacaine plasma concentrations
Maternal venous blood samples (5-ml heparinized) were withdrawn through an i.v. cannula and three-way tap inserted to a vein in the arm contralateral to that receiving the i.v. infusion.
Samples were taken just before the 20-ml bupivacaine dose in the emergency Caesarean section group (0 min) and after 10, 20, 30 and 45 min in all patients. After separation by centrifugation, plasma samples were stored at 4 °C until assayed. Bupivacaine was measured by gas chromatography using the method of Reynolds and Beckett [8] , but with l-ethyl-2',6'-pipecholylxylidine, the ethyl homologue of bupivacaine, as the internal marker, 3% OV17 as stationary phase, and a nitrogen detector.
Statistics
Statistical evaluation of the data was carried out using the SAS Statistical Package running on the Amdahl V8 computer at the University of London Computer Centre. The GLM procedure was used to perform a repeated measures Analysis of Variance on plasma concentrations. One-way analysis of variance with Tukey's multiple comparison test, Student's t test, Kruskall-Wallis test, Fisher's exact test or the Chi-square test were used for all other calculations.
RESULTS
The clinical data are shown in table I. There were no significant differences in age, weight or height between the groups.
The doses of bupivacaine required for Caesarean section are shown in table II. Significantly more women in the elective plain group than in the emergency groups required more than the initial 100-mg dose for Caesarean section. The emergency patients were given a wide range of doses of bupivacaine during labour (table III) and there was no significant difference between plain and adrenaline groups in total dose, duration of analgesia during labour, number of additional doses or the time interval from last "top-up" to the dose before the Caesarean section.
Efficacy of extradural block for surgery
Details of the efficacy of the block in the elective group are presented elsewhere [7] . In table IV the requirement for analgesic supplementation after the initial 100-mg dose of bupivacaine for Caesarean section is summarized. The elective plain group needed significantly more supplementary analgesia compared with the other three groups (P < 0.05). One patient in the emergency group received general anaesthesia as she developed sudden unmanageable fear despite an apparently satisfactory extradural block. Extradural anaesJiesia was sufficient alone in 32 elective patients (80%) and 37 emergency patients (93%). The modal height of block had reached T3 at 30 min in 48 % of elective patients and 45 % of emergency patients. Adrenaline had no effect on spread of extradural block.
Plasma bupivacaine concentrations
Mean plasma bupivacaine concentrations in the four groups are shown in figure 1. In the elective group, extradural adrenaline was associated with a significant reduction in bupivacaine concentrations, but in those who received only bupivacaine 100 mg (table II) there were no significant differences between the plain and adrenaline groups. In the emergency group adrenaline had no significant effect on bupivacaine concentration. Bupivacaine concentrations were significantly greater (P < 0.0001) in the combined emergency groups than in the combined elective groups ( fig. 2) , but not significantly different in the combined adrenaline groups compared with the combined plain groups (fig. 3) .
The use of extradural adrenaline was not associated with a significant reduction in maximum bupivacaine concentration (C max ) (table V) . Time to C max was significantly longer in the elective plain group than in the other three groups (P < 0.01), reflecting the fact that more supplementary doses of bupivacaine were necessary in the elective plain group. C max increased significantly with dosage of bupivacaine (mg kg" 1 ) in the whole population (r = 0.618; P < 0.0001) and in the elective (P < 0.001), emergency (P < 0.026), plain (P < 0.0002) and adrenaline (P < 0.0001) groups (fig. 4) . C max was negatively correlated (r = -0.425; P < 0.001) with bupivacaine dose rate (total dose/first dose to delivery interval). In only three patients did C max exceed the oft quoted minimum toxic threshold of 1.6ngml~l [9] [10] [11] . All had received plain bupivacaine. One elective patient (1.97 ug ml" 1 ) had received the unusually high dose of bupivacaine 275 mg (3.7 ug ml" 1 ) over a 2-h period while two emergency patients (1.73 and 1.86 ug ml" 1 ) had both received bupivacaine 100 mg for Caesarean section following only 87 mg and 103 mg, respectively, during labour.
Complications
Drowsiness was observed in 16 patients who had maximum plasma bupivacaine concentrations ranging from 0.53 to 1.53 ug ml" 1 . However, none of the three patients with maximum bupivacaine concentrations greater than 1.6 ug ml" 1 had symptoms of toxicity. No other toxic symptoms occurred.
The incidence of hypotension, nausea, vomiting and shivering among the four groups is given in table VI. In the elective group, shivering occurred more frequently after adrenaline than after plain solution (P < 0.05). There were no other significant differences among the groups.
DISCUSSION
Our study with 0.5 % bupivacaine confirms the general belief that adrenaline may improve the efficacy of extradural local anaesthesia [12] , but this effect was seen only in association with elective Caesarean section, as the standard 100-mg dose was less likely to require enhancement by adrenaline in the presence of pre-existing extradural blockade. Adrenaline may be necessary to fortify rather low doses. Thus Littlewood and coworkers [13] found that adrenaline only improved analgesia with the more dilute solutions of bupivacaine (0.25 % and 0.125 %), and Eisenach, Grice and Dewan [14] reported that adrenaline, added to 10 ml of 0.25% bupivacaine, improved analgesia in labour. Adrenaline has been reported to reduce mean peak plasma concentrations of both lignocaine and bupivacaine in non-pregnant patients [15] . In our study, adrenaline was associated with significantly reduced bupivacaine concentrations only in patients undergoing elective Caesarean section; however, this effect was not observed when comparing those patients who received only the initial dose of bupivacaine 100 mg. This suggests that, in this study, any reduction in plasma bupivacaine concentration was associated with a reduced dose requirement rather than with slower systemic absorption of the drug, a finding which is of clinical relevance. Adrenaline did not usefully reduce plasma bupivacaine concentration in the emergency Caesarean section group, in which the two subgroups received similar doses of bupivacaine for Caesarean section. All these women had, moreover, received plain bupivacaine for routine extradural analgesia during labour.
Relatively high plasma bupivacaine concentrations during Caesarean section were reported by Thompson and colleagues [4] . However, their calculations measured bupivacaine as the hydrochloride salt. True bupivacaine concentrations would, therefore, be 88 % of those reported. In addition, as the internal marker they used lignocaine, which is notoriously unreliable compared with the ethyl-pipecholylxylidine used here (F. Reynolds, personal observation; R. Boyes, personal communication). Our results do not support their view that a single-dose extradural injection for elective Caesarean section leads to plasma bupivacaine concentrations similar to those observed in emergency Caesarean section. The different rates of injection, 20 ml over 20 s in their study compared with 10 min in the present study, may also account for these differences. As there is no clinical advantage from rapid injection [16] we advocate slow injection, which will also reduce the danger from accidental i.v. injection [17] .
The relationship of C max to drug dosage may predict the risk of reaching the threshold of toxicity. The results of our study show that there is a good correlation (P < 0.0001) between C raax and bupivacaine dose ( fig. 4) [2] that maternal bupivacaine concentration is dependent on total dose rather than dose rate and reflects the fact that, during continuous administration at a constant rate, plasma concentrations of a drug reach a plateau between four to seven half-lives. Alterations in dose rate preferentially affect the ultimate plateau concentration, which is unlikely to be attained during the course of labour.
The only symptom of bupivacaine toxicity was drowsiness, which was not always observed in those patients with high bupivacaine concentrations. This emphasizes the variability among patients in their susceptibility to local anaesthetic toxicity. Shivering, which occurred in 50% of patients, has been attributed to stimulation of thermosensitive tissue in the extradural space [18] .
From our study, we conclude that adrenaline may improve the effectiveness of extradural anaesthesia in elective Caesarean section, but only usefully reduces plasma bupivacaine concentration in pregnant women by vircue of reducing the dose requirement. In addition, we conclude that, using our technique, plasma concentrations of bupivacaine do not often reach the toxic threshold and, although systemic reactions may result from inadvertent i.v. injection or excessive dosage, they are unlikely to follow the correct extradural placement of an appropriate dose of bupivacaine.
